Heron Therapeutics, Inc.
HRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818033
No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Heron Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 151 | 161 | +10 |
| Shares | 112.5M | 119.4M | +6.90M (+6.1%) |
| Value | $191.2M | $330.5M | +$139.3M (+72.9%) |
New holders (28)
Institutions that held Heron Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (18)
Institutions that held Heron Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| HRT Financial LP | 199,908 | $339.0K |
| Acadian Asset Management LLC | 134,877 | $229.0K |
| Propel Bio Management, LLC | 104,195 | $177.1K |
| Weiss Multi-Strategy Advisers LLC | 90,000 | $153.0K |
| Captrust Financial Advisors | 51,102 | $86.9K |
| Virtu Financial LLC | 41,237 | $70.0K |
| X-Square Capital, LLC | 31,185 | $53.0K |
| SG Americas Securities, LLC | 26,464 | $45.0K |
| Simplex Trading, LLC | 20,598 | $35.0K |
| Bayesian Capital Management, LP | 20,300 | $34.5K |
| Point72 Middle East FZE | 18,500 | $31.4K |
| Estate Counselors, LLC | 17,000 | $28.9K |
| National Asset Management, Inc. | 11,490 | $19.5K |
| Douglas Lane & Associates, LLC | 10,000 | $17.0K |
| Advisory Services Network, LLC | 1,479 | $2.51K |
| Raleigh Capital Management Inc. | 1,453 | $2.47K |
| ORG Partners LLC | 400 | $680 |
| National Bank of Canada | 100 | $188 |